Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.
- NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_assertion description "[Metformin also inhibited CD61(high)/CD49f(high) subpopulation in MMTV-ErbB2 tumor-derived cells, which was correlated with their compromised tumor initiation/development in a syngeneic tumor graft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.
- NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_assertion evidence source_evidence_literature NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.
- NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_assertion SIO_000772 24322659 NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.
- NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_assertion wasDerivedFrom befree-20150227 NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.
- NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_assertion wasGeneratedBy ECO_0000203 NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP518026.RAobeX9Fg_VFQWi6EZ0uUlAR1-ldKy5b6Zjw4HEf_vuwA130_provenance.